Stocktoria

Personalis, Inc. PSNL

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2019-06-20 · LEI

Personalis, Inc. financials (annual)

Revenue
$37.8M $65.2M $78.6M $85.5M $65.0M $73.5M $84.6M $69.6M 20182019202020212022202320242025
Net income
-$19.9M -$25.1M -$41.3M -$65.2M -$113.3M -$108.3M -$81.3M -$81.3M 20182019202020212022202320242025
Free cash flow
-$2.3M -$26.5M -$45.9M -$81.9M -$120.1M -$67.2M -$46.8M -$79.5M 20182019202020212022202320242025

Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$69.6M$84.6M$73.5M$65.0M$85.5M$78.6M$65.2M$37.8M
R&D expense$50.3M$48.9M$64.8M$64.9M$49.3M$28.6M$22.4M$14.3M
SG&A expense$53.6M$46.2M$49.7M$64.0M$47.7M$33.7M$22.1M$11.3M
Operating income-$88.1M-$68.3M-$109.9M-$115.5M-$65.4M-$42.1M-$22.4M-$13.8M
Interest expense$205,000$24,000$110,000$201,000$184,000$2,000$1.1M$1.9M
Income tax$21,000$18,000$83,000$40,000$14,000$57,000$9,000$7,000
Net income-$81.3M-$81.3M-$108.3M-$113.3M-$65.2M-$41.3M-$25.1M-$19.9M
EPS (diluted)$-0.91$-1.37$-2.25$-2.48$-1.49$-1.20
Operating cash flow-$74.9M-$45.1M-$56.3M-$70.2M-$70.8M-$42.7M-$18.1M$5.6M
Free cash flow-$79.5M-$46.8M-$67.2M-$120.1M-$81.9M-$45.9M-$26.5M-$2.3M
Cash & equivalents$124.2M$91.4M$57.0M$89.1M$105.6M$68.5M$55.0M$19.7M
Total assets$334.2M$270.3M$225.1M$292.7M$396.5M$244.8M$157.3M$41.7M
Total liabilities$73.0M$67.3M$95.7M$74.6M$86.2M$49.9M$50.6M$58.7M
Shareholders' equity$261.2M$203.0M$129.4M$218.1M$310.3M$194.9M$106.7M-$106.4M

Growth · year-over-year · Revenue CAGR 9.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue growth-17.7%+15.2%+13.0%-23.9%+8.7%+20.6%+72.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.